1. Home
  2. ITOS vs PERI Comparison

ITOS vs PERI Comparison

Compare ITOS & PERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • PERI
  • Stock Information
  • Founded
  • ITOS 2011
  • PERI 1999
  • Country
  • ITOS United States
  • PERI Israel
  • Employees
  • ITOS N/A
  • PERI N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • PERI EDP Services
  • Sector
  • ITOS Health Care
  • PERI Technology
  • Exchange
  • ITOS Nasdaq
  • PERI Nasdaq
  • Market Cap
  • ITOS 342.6M
  • PERI 378.7M
  • IPO Year
  • ITOS 2020
  • PERI 2006
  • Fundamental
  • Price
  • ITOS $8.32
  • PERI $8.52
  • Analyst Decision
  • ITOS Strong Buy
  • PERI Hold
  • Analyst Count
  • ITOS 3
  • PERI 5
  • Target Price
  • ITOS $33.67
  • PERI $10.17
  • AVG Volume (30 Days)
  • ITOS 543.4K
  • PERI 373.6K
  • Earning Date
  • ITOS 11-12-2024
  • PERI 11-06-2024
  • Dividend Yield
  • ITOS N/A
  • PERI N/A
  • EPS Growth
  • ITOS N/A
  • PERI N/A
  • EPS
  • ITOS N/A
  • PERI 0.93
  • Revenue
  • ITOS $35,000,000.00
  • PERI $602,939,000.00
  • Revenue This Year
  • ITOS $271.18
  • PERI N/A
  • Revenue Next Year
  • ITOS N/A
  • PERI N/A
  • P/E Ratio
  • ITOS N/A
  • PERI $9.19
  • Revenue Growth
  • ITOS N/A
  • PERI N/A
  • 52 Week Low
  • ITOS $7.54
  • PERI $7.47
  • 52 Week High
  • ITOS $18.75
  • PERI $32.99
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 39.51
  • PERI 52.20
  • Support Level
  • ITOS $7.54
  • PERI $8.31
  • Resistance Level
  • ITOS $8.38
  • PERI $9.29
  • Average True Range (ATR)
  • ITOS 0.53
  • PERI 0.35
  • MACD
  • ITOS 0.01
  • PERI -0.05
  • Stochastic Oscillator
  • ITOS 35.94
  • PERI 17.45

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

Share on Social Networks: